Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cidara Therapeutics (CDTX) Debt Ratio: 2017-2022

Historic Debt Ratio for Cidara Therapeutics (CDTX) over the last 5 years, with Jun 2022 value amounting to 0.01.

  • Cidara Therapeutics' Debt Ratio fell 87.54% to 0.01 in Q2 2022 from the same period last year, while for Jun 2022 it was 0.01, marking a year-over-year decrease of 87.54%. This contributed to the annual value of 0.03 for FY2021, which is 70.41% down from last year.
  • Latest data reveals that Cidara Therapeutics reported Debt Ratio of 0.01 as of Q2 2022, which was down 65.02% from 0.03 recorded in Q1 2022.
  • In the past 5 years, Cidara Therapeutics' Debt Ratio registered a high of 0.19 during Q2 2019, and its lowest value of 0.01 during Q2 2022.
  • Moreover, its 3-year median value for Debt Ratio was 0.09 (2021), whereas its average is 0.08.
  • Per our database at Business Quant, Cidara Therapeutics' Debt Ratio spiked by 34.58% in 2019 and then crashed by 87.54% in 2022.
  • Over the past 5 years, Cidara Therapeutics' Debt Ratio (Quarterly) stood at 0.13 in 2018, then increased by 15.12% to 0.14 in 2019, then fell by 19.55% to 0.12 in 2020, then tumbled by 70.41% to 0.03 in 2021, then crashed by 87.54% to 0.01 in 2022.
  • Its Debt Ratio was 0.01 in Q2 2022, compared to 0.03 in Q1 2022 and 0.03 in Q4 2021.